Crossmark

Advanced glycation end products and their ratio to soluble receptor are associated with limitations in physical functioning only in women: results from the CARLA cohort

Crossref DOI link: https://doi.org/10.1186/s12877-019-1323-8

Published Online: 2019-11-04

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ebert, Helen

Lacruz, Maria Elena

Kluttig, Alexander

Simm, Andreas

Greiser, Karin Halina

Tiller, Daniel

Kartschmit, Nadja

Mikolajczyk, Rafael https://orcid.org/0000-0003-1271-7204
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (CRC - 598)

Wilhelm Roux Program (14/41, 16/19)

Federal Employment Office, Saxony Anhalt (MKCARLA- MLU-2011)

personal intramural project funding (PK26)
License Information

Text and Data Mining valid from 2019-11-04

Version of Record valid from 2019-11-04
More Information

Article History

Received: 15 April 2019

Accepted: 17 October 2019

First Online: 4 November 2019

Ethics approval and consent to participate

: All CARLA participants gave their written informed consent. The local ethics committee of the Medical Faculty of the Martin-Luther-University Halle-Wittenberg and the State Data Privacy Commissioner of Saxony-Anhalt approved the study. The CARLA study conforms to the principles outlined in the declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below